Release Date: 13/03/09 12:56 Summary: Shares moved to Issuer Sponsorship Price Sensitive: No Download Document 336.92KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%